In vivo near-infrared fluorescence imaging of cancer with nanoparticle-based probes

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 2, Issue 4, 2010, Pages 349-366

  He, Xiaoxiao ^a,b   Wang, Kemin ^b   Cheng, Zhen ^a  

^a STANFORD UNIVERSITY   (United States)

^b HUNAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOFLUORESCENCE; BIOLOGICAL TISSUES; CANCER IMAGING; DETECTION SENSITIVITY; EARLY DETECTION; IN-VIVO; MOLECULAR IMAGING; MOLECULAR PROBES; NEAR-INFRARED FLUORESCENCE; NEAR-INFRARED FLUORESCENCE IMAGING; NIR SPECTRUM; ORGANIC DYE; PHOTO-STABILITY; QUANTUM DOT; SURFACE MODIFICATION; UP-CONVERSION;

ABSORPTION SPECTROSCOPY; FLUORESCENCE; INFRARED DEVICES; INFRARED SPECTROSCOPY; MEDICAL IMAGING; PROBES;

NANOPARTICLES;

3 AMINOPROPYLTRIETHOXYSILANE; APOLIPOPROTEIN; BOVINE SERUM ALBUMIN; CALCIUM PHOSPHATE; DYE; EDETIC ACID; ERBIUM; FLUORESCEIN ISOTHIOCYANATE; FLUORIDE; FOLIC ACID; HIGH DENSITY LIPOPROTEIN; LANTHANUM FLUORIDE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; NANOPARTICLE; QUANTUM DOT; RENILLA LUCIFERIN 2 MONOOXYGENASE; SMALL INTERFERING RNA; SODIUM YTTRIUM FLUORIDE; THULIUM; TRIFLUOROACETIC ACID; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR; YTTERBIUM;

APOPTOSIS; BIOCOMPATIBILITY; BIODEGRADABILITY; BIOLOGY; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; C57BL 6 MOUSE; CAENORHABDITIS ELEGANS; CELL STRAIN HEPG2; CELL STRAIN KB; CELL STRAIN MCF 7; CHO CELL; COLON CANCER; EARLY DIAGNOSIS; FLUORESCENCE; FLUORESCENCE IMAGING; HUMAN; HYDROPHILICITY; IN VIVO STUDY; LEWIS CARCINOMA; LYMPHOCYTE; MICROEMULSION; MOLECULAR IMAGING; NEAR INFRARED FLUORESCENCE; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTUM YIELD; REVIEW; SENSITIVITY ANALYSIS; TUMOR XENOGRAFT;

ANIMALS; FLUORESCENT DYES; HUMANS; NANOPARTICLES; NEOPLASMS; SPECTROMETRY, FLUORESCENCE; SPECTROSCOPY, NEAR-INFRARED; WHOLE BODY IMAGING;

EID: 77955488728     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.85     Document Type: Review

References (134)

1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics. CA Cancer J Clin 2000, 50:7-33.
2. 3-targeted magnetic resonance imaging. Nat Med 1998, 4:623-626.
3. Wit MD, Bumann D, Beyer W, Herbst K, Clausen M, et al. Whole-body positron emission tomography (PET) for diagnosis of residual mass in patients with lymphoma. Ann Oncol 1997, 8:57-60.
4. Paulus MJ, Gleason SS, Kennel SJ, Hunsicker PR, Johnson DK. High resolution X-ray computed tomography: an emerging tool for small animal cancer research. Neoplasia 2000, 2:62-67.
5. Muhm JR, Miller WE, Fontana RS, Sanderson DR, Uhlenhopp MA. Lung cancer detected during a screening program using four-month chest radiographs. Radiology 1983, 148:609-615.
6. Warner BE, Plewes DB, Shumak RS, Catzavelos GC, Di Prospero LS, et al. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. Int J Clin Oncol 2001, 19:3524-3531.
7. Wang YW, Xie XY, Wang XD, Ku G, Gill KL, et al. Photoacoustic tomography of a nanoshell contrast agent in the in vivo rat brain. Nano Lett 2004, 4:1689-1692. (Pubitemid 39297446)
8. Ballou B, Ernst LA, Waggoner AS. Fluorescence imaging of tumors in vivo. Curr Med Chem 2005, 12:795-805.
9. Andersson-Engels S, Klinteberg CA, Svanberg K, Svanberg S. In vivo fluorescence imaging for tissue diagnostics. Phys Med Biol 1997, 42:815-824.
10. Zeng HS, Weiss A, Cline R, MacAulayy CE. Realtime endoscopic fluorescence imaging for early cancer detection in the gastrointestinal tract. Bioimaging 1998, 6:151-165.
11. Choy G, Choyke P, Libutti SK. Current advances in molecular imaging: noninvasive in vivo bioluminescent and fluorescent optical imaging in cancer research. Mol Imaging 2003, 2:303-312.
12. Sima PD, Kanofsky JR. Cyanine dyes as protectors of K562 cells from photosensitized cell damage. Photochem Photobiol 2000, 71:413-421.
13. Rohand T, Qin W, Boens N, Dahaen W. Palladiumcatalyzed coupling reactions for the functionalization of BODIPY dyes with fluorescence spanning the visible spectrum. Eur J Org Chem 2006, 20:4658-4663.
14. Ho N, Weissleder R, Tung CH. Development of water-soluble far-red fluorogenic dyes for enzyme sensing. Tetrahedron 2006, 62:578-585.
15. Hintersteiner M, Enz A, Frey P, Jaton AL, Kinzy W, et al. In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe. Nat Biotechnol 2005, 5:577-583.
16. Rao JH, Andrasi AD, Rao HQ. Fluorescence imaging in vivo: recent advances. Curr Opin Biotechnol 2007, 18:17-25.
17. Becker A, Hessenius C, Licha K, Ebert B, Sukowski U, et al. Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands. Nat Biotechnol 2001, 19:327-331.
18. Newton JR, Kellyy KA, Mahmoody U, Weissledery R, Deutscher SL. In vivo selection of phage for the optical Imaging of PC-3 human prostate carcinoma in mice. Neoplasia 2006, 8:772-780.
19. Frangioni JV. In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol 2003, 7:626-634.
20. Kong G, Braun RD, Dewhirst MW. Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size. Cancer Res 2000, 60:4440-4445.
21. Yang XM, Stein EW, Ashkenazi S, Wang LV. Nanoparticles for photoacoustic imaging. WIREs Nanomed Nanobiotechnol 2009, 1:360-368.
22. Yang X, Skrabalak SE, Li ZY, Xia Y, Wang LV. Photoacoustic tomography of a rat cerebral cortex in vivo with Au nanocages as an optical contrast agent. Nano Lett 2007, 7:3798-3802.
23. Lanza GM, Winter PM, Caruthers SD, Morawskia AM, Schmieder AH, et al. Magnetic resonance molecular imaging with nanoparticles. J Nucl Cardiol 2004, 11:733-743.
24. Lee JH, Huh YM, Jun YW, Seo YW, Jang JT, et al. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med 2006, 13:95-99.
25. Keren S, Zavaleta C, Cheng Z, de la Zerda A, Gheysens O, et al. Noninvasive molecular imaging of small living subjects using Raman spectroscopy. Proc Natl Acad Sci USA 2008, 105:5844-5849.
26. Zavaleta C, de la Zerda A, Liu Z, Keren S, Cheng Z, et al. Noninvasive Raman spectroscopy in living mice for evaluation of tumor targeting with carbon nanotubes. Nano Lett 2008, 8:2800-2805.
27. Sharma P, Brown S, Walter G, Santra S, Moudgil B. Nanoparticles for bioimaging. Adv Colloid Interface Sci 2006, 123-126:471-485.
28. Bentolila LA, Ebenstein Y, Weiss S. Quantum dots for in vivo small-animal imaging. J Nucl Med 2009, 50:493-496.
29. Santra S, Dutta D, Walter GA, Moudgil BM. Fluorescent nanoparticle probes for cancer imaging. Technol Cancer Res Treat 2005, 4:594-602.
30. Bagwe RP, Zhao X, Tan WH. Bioconjugated luminescent nanoparticles for biological applications. J Dispersion Sci Technol 2003, 3-4:453-464.
31. Santra S,Wang KM, Tapec R, Tan WH. Development of novel dye-doped silica nanoparticles for biomarker application. J Biomed Opt 2001, 6:160-166.
32. He XX, Lin X, Wang KM, Tan WH, Chen L, et al. In: Nalwa HS, ed. Biocompatible coreoe-shell nanoparticles for biomedicine, Encyclopedia of Nanoscience and Nanotechnology, vol. 1. Los Angeles: American Scientific Publishers; 2004, 235-253.
33. Santra S, Zhang P, Wang KM, Tapec R, Tan WH. Conjugation of biomolecules with luminophoredoped silica nanoparticles for photostable biomarkers. Anal Chem 2001, 73:4988-4993.
34. Herr JK, Smith JE, Medley CD, Shangguan DH, Tan WH. Aptamer-conjugated nanoparticles for selective collection and detection of cancer cells. Anal Chem 2006, 78:2918-2924.
35. He XX, Wang KM, Tan WH, Yang XH, Huang SS, et al. Photostable luminescent nanoparticles as biological label for cell recognition of system lupus erythematosus patients. JNanosci Nanotechnol 2001, 2:317-320.
36. He XX, Duan JH, Wang KM, Tan WH, Lin X, et al. A novel fluorescent label based on organic dye-doped silica nanoparticles for HepG liver cancer cell recognition. J Nanosci Nanotechnol 2004, 4:585-589.
37. Shi H, He XX, Wang KM, Yuan Y, Deng K, et al. Rhodamine B isothiocyanate doped silica-coated fluorescent nanoparticles (RBITC-DSFNPs)-based bioprobes conjugated to Annexin V for apoptosis detection and imaging. Nanomed Nanotechnol Biol Med 2007, 3:266-272.
38. Santra S, Yang H, Holloway PH, Stanley JT, Mericle RA. Conjugated fluorescent silica nanoparticles for labeling neoplastic cells. JNanosci Nanotechnol 2005, 5:899-904.
39. He XX, Chen JY, Wang KM, Qin DL, Tan WH. Preparation of luminescent Cy5 doped core - shell SFNPs and its application as a near-infrared fluorescent marker. Talanta 2007, 72:1519-1526.
40. Zhou XC, Zhou JZ. Improving the signal sensitivity and photostability of DNA hybridizations on microarrays by using dye-doped core-shell silica nanoparticles. Anal Chem 2004, 76:5302-5312.
41. Klein LC. Sol - gel processing of silicates. Annu Rev Mater Sci 1985, 15:227-248.
42. Lee CH, Cheng SH, Wang YJ, Chen YC, Chen NT, et al. Near-infrared mesoporous silica nanoparticles for optical imaging: characterization and in vivo biodistribution. Adv Funct Mater 2009, 19:215-222.
43. le Masne deChermont Q, Chaneac C, Seguin J, Pelle F, et al. Nanoprobes with near-infrared persistent luminescence for in vivo imaging. Proc Natl Acad Sci USA 2007, 104:9266-9271.
44. Dorozhkin SV, Epple M. Biological and medical significance of calcium phosphates. Angew Chem Int Ed 2002, 41:3130-3146.
45. Bisht S, Bhakta G, Mitra S, Maitra A. pDNA loaded calcium phosphate nanoparticles: highly efficient nonviral vector for gene delivery. Int J Pharm 2005, 288:157-168.
46. Kester M, Heakal Y, Fox T, Sharma A, Robertson GP, et al. Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells. Nano Lett 2008, 8:4116-4121.
47. Muddana HS, Morgan TT, Adair JH, Butler PJ. Photophysics of Cy3-encapsulated calcium phosphate nanoparticles. Nano Lett 2009, 19:1559-1566.
48. Morgan TT, Muddana HS, Altinoǧlu EI, Rouse SM, Tabakovic A, et al. Encapsulation of organic molecules in calcium phosphate nanocomposite particles for intracellular imaging and drug delivery. Nano Lett 2008, 8:4108-4115.
49. Altinoǧlu EI, Russin TJ, Kaiser JM, Barth BM, Eklund PC, et al. Near-infrared emitting fluorophoredoped calcium phosphate nanoparticles for in vivo imaging of human breast cancer. ACS Nano 2008, 2:2075-2084.
50. Bruns OT, Ittrich H, Peldschus K, Kaul MG, Tromsdorf UI, et al. Real-time magnetic resonance imaging and quantification of lipoprotein metabolism in vivo using nanocrystals. Nat Nanotechnol 2009, 4:193-200.
51. Linsel-Nitschke P, Tall AR. HDL as a target in the treatment of atherosclerotic cardiovascular disease. Nat Rev Drug Discov 2005, 4:193-205.
52. Rensen PC, de Vrueh RL, Kuiper J, Bijsterbosch MK, Biessen EA, et al. Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting. Adv Drug Delivery Rev 2001, 47:251-276.
53. Urizzi P, Souchard JP, Palevody C, Ratovo G, Hollande E, et al. Internalization of indium-labeled LDL through a lipid chelating anchor in human pancreatic-cancer cells as a potential radiopharmaceutical for tumor localization. Int J Cancer 1997, 70:315-322.
54. Krieger M, Goldstein JL, Brown MS. Receptor-mediated uptake of low density lipoprotein reconstituted with 25-hydroxycholesteryl oleate suppresses 3-hydroxy-3-methylglutarylcoenzyme A reductase and inhibits growth of human fibroblasts. Proc Natl Acad Sci USA 1978, 75:5052-5056.
55. Moerlein SM, Daugherty A, Sobel BE, Welch MJ. Metabolic imaging with gallium-68- and indium-111-labeled low-density lipoprotein. Nucl Med 1991, 32:300-307.
56. Cormode DP, Briley-Saebo KC, Mulder WJM, Aguinaldo JGS, Barazza A, et al. An apoA-I mimetic peptide high-density-lipoprotein-based MRI contrast agent for atherosclerotic plaque composition detection. Small 2008, 4:1437-1444.
57. Zheng G, Li H, Yang K, Blessington D, Licha K, et al. Tricarbocyanine cholesteryl laurates labeled LDL: new near infrared fluorescent probes (NIRFs) for monitoring tumors and gene therapy of familial hypercholesterolemia. Bioorg Med Chem Lett 2002, 12:1485-1488.
58. Li H, Zhang ZH, Blessington D, Nelson DS, Zhou R, et al. Carbocyanine labeled LDL for optical imaging of tumors. Acad Radiol 2004, 11:669-677.
59. Zheng G, Chen J, Li H, Glickson JD. Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents. Proc Natl Acad Sci USA 2005, 102:17757-17762.
60. Chen J, Corbin IR, Li H, Cao WG, Glickson JD, et al. Ligand conjugated low-density lipoprotein nanoparticles for enhanced optical cancer imaging in vivo. J Am Chem Soc 2007, 129:5798-5799. (Pubitemid 46748467)
61. Alivisatos AP. Semiconductor clusters, nanocrystals, and quantum dots. Science 1996, 271:933-937.
62. Chan WCW, Nie SM. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 1996, 281:2016-2018.
63. Alivisatos AP. Perspectives on the physical chemistry of semiconductor nanocrystals. J Phys Chem 1996, 100:13226-13239.
64. Goldman ER, Medintz IL, Mattoussi H. Luminescent quantum dots in immunoassays. Anal Bioanal Chem 2006, 384:560-563.
65. Han MY, Gao XH, Su JZ, Nie SM. Quantum-dot-tagged microbeads for multiplexed optical coding of biomolecules. Nat Biotechnol 2001, 19:631-635.
66. Medintz IL, Clapp AR, Brunel FM, Tiefenbrunn T, Uyeda HT, et al. Proteolytic activity monitored by fluorescence resonance energy transfer through quantum-dot-peptide conjugates. Nat Mater 2006, 5:581-589.
67. Zheng Y, Gao S, Ying JY. Synthesis and cell-imaging applications of glutathione-capped CdTe quantum dots. Adv Mater 2007, 19:376-380.
68. Michalet X, Pinaud FF, Bentolila LA, Tsay JM, Doose S, et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005, 307:539-544.
69. Smith AM, Gao XH, Nie SM. Quantum dot nanocrystals for in vivo molecular and cellular imaging. Photochem Photobiol 2004, 80:377-385.
70. Medintz IL, Uyeda HT, Goldman ER, Mattoussi H. Quantum dot bioconjugates for imaging, labelling and sensing. Nat Mater 2005, 4:435-446.
71. Weissleder R. A clearer vision for in vivo imaging. Nat Biotechnol 2001, 19:316-317.
72. Hyun BR, Chen H, Rey DA, Wise FW, Batt CA. Near-infrared fluorescence imaging with water-soluble lead salt quantum dots. J Phys Chem B 2007, 111:5726-5730.
73. Bailey RE, Nie SM. Alloyed semiconductor quantum dots: tuning the optical properties without changing the particle Size. J Am Chem Soc 2003, 125:7100-7106.
74. 1-x alloyed quantum dots for biomedical imaging. Chem Mater 2006, 18:4845-4854.
75. Dabbousi BO, Rodriguez-Viejo J, Mikulec FV, Heine JR, Mattoussi H, et al. (CdSe)ZnS core - shell quantum dots: synthesis and characterization of a size series of highly luminescent nanocrystallites. J Phys Chem B 1997, 101:9463-9475.
76. 1-x/In P/ZnSe III-V alloyed core/shell quantum dots for the nearinfrared. J Am Chem Soc 2005, 127:10526-10532.
77. Bailey RE, Strausburg JB, Nie SM. A new class of far-red and near-infrared biological labels based on alloyed semiconductor quantum dots. J Nanosci Nanotechnol 2003, 4:569-574.
78. Chang JY, Wang SR, Yang CH. Synthesis and characterization of CdTe/CdS and CdTe/CdSe core/shell type-II quantum dots in a noncoordinating solvent. Nanotechnology 2007, 18(345602):(6 p.).
79. Mao WY, Guo J, Yang WL, Wang CC, He J, et al. Synthesis of high-quality near-infrared-emitting CdTeS alloyed quantum dots via the hydrothermal method. Nanotechnology 2007, 18:485611 (7 p.).
80. Morgan NY, English S, Chen W, Chernomordik V, Russo A, et al. Real time in vivo non-invasive optical imaging using near-infrared fluorescent quantum dots. Acad Radiol 2005, 12:313-323.
81. Harrison MT, Kershaw SV, Burt MG, Eychmuller A, Weller H, et al. Wet chemical synthesis and spectroscopic study of CdHgTe nanocrystals with strong near-infrared luminescence. Mater Sci Eng B Solid State Mater Adv Technol 2000, B69-B70:355-360.
82. So MK, Xu C, Loening AM, Gambhir SS, Rao JH. Self-illuminating quantum dot conjugates for in vivo imaging. Nat Biotechnol 2006, 24:339-343.
83. Xing Y, So MK, Koh AL, Sinclair R, Rao JH. Improved QD-BRET conjugates for detection and imaging. Biochem Biophys Res Commun 2008, 372:388-394.
84. So MK, Loening AM, Gambhir SS, Rao JH. Creating self-illuminating quantum dot conjugates. Nat Protocol 2006, 1:1160-1164.
85. Jin T, Fujii F, Komai Y, Seki J, Seiyama A, et al. Preparation and characterization of highly fluorescent, glutathione-coated near infrared quantum dots for in vivo fluorescence imaging. Int J Mol Sci 2008, 9:2044-2061.
86. Gao XH, Yang LL, Petros JA, Marshall FF, Simons JW, et al. In vivo molecular and cellular imaging with quantum dots. Curr Opin Biotechnol 2005, 16:63-72.
87. Pons T, Lequeux N, Mahler B, Sasnouski S, Fragola A, et al. Synthesis of near-infrared-emitting, watersoluble CdTeSe/CdZnS core/shell quantum dots. Chem Mater 2009, 21:1418-1424.
88. Yong KT. Mn-doped near-infrared quantum dots as multimodal targeted probes for pancreatic cancer imaging. Nanotechnology 2009, 20:015102 (10 p.).
89. Cai WB, Chen XY. Preparation of peptide-conjugated quantum dots for tumor vasculature-targeted imaging. Nat Protocol 2008, 3:89-96.
90. Cai W, Shin DW, Chen K, Gheysens O, Cao QZ, et al. Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano Lett 2006, 6:669-676.
91. Kim S, Lim YT, Soltesz EG, De Grand AM, Lee J, et al. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol 2004, 22:93-97.
92. Hama Y, Koyama Y, Urano Y, Choyke PL, Kobayashi H. Simultaneous two-color spectral fluorescence lymphangiography with near infrared quantum dots to map two lymphatic flows from the breast and the upper extremity. Breast Cancer Res Treat 2007, 103:23-28.
93. Kobayashi H, Koyama Y, Barrett T, Hama Y, Regino CAS, et al. Multimodal nanoprobes for radionuclide and five-color near-infrared optical lymphatic imaging. ACS Nano 2007, 1:258-264.
94. Smith BR, Cheng Z, De A, Koh AL, Sinclair R, et al. Real-time intravital imaging of RGD-quantum dot binding to luminal endothelium in mouse tumor neovasculature. Nano Lett 2008, 8:2599-2606.
95. Diagaradjane P, Orenstein-Cardona JM, Colon-Casasnovas NE, Deorukhkar A, Shentu S, et al. Imaging epidermal growth factor receptor expression in vivo: pharmacokinetic and biodistribution characterization of a bioconjugated quantum dot Nanoprobe. Clin Cancer Res 2008, 14:731-741.
96. 4:Yb, Er upconversion nanoparticles. ACS Nano 2009, 3:1580-1586.
97. Jalil RA, Zhang Y. Biocompatibility of silica coated NaYF4 upconversion fluorescent nanocrystals. Biomaterials 2008, 29:4122-4128.
98. Auzel F. Upconversion and anti-stokes processes with f and d ions in solids. Chem Rev 2004, 104:139-173.
99. Jiang S, Zhang Y, Lim KM, Sim EKW, Ye L. NIR-to-visible upconversion nanoparticles for fluorescent labeling and targeted delivery of siRNA. Nanotechnology 2009, 20:155101 (9 p.).
100. 4:Yb, Er infrared-to-visible up-conversion phosphors. Nano Lett 2004, 4:2191-2196.
101. 3 nanoparticles, hetero-looping-enhanced energy transfer (Hetero-LEET): a new up-conversion process. J Am Chem Soc 2007, 129:620-625.
102. 3+ via thermal decomposition of lanthanide trifluoroacetate precursors. J Am Chem Soc 2006, 128:7444-7445.
103. 3+ monodisperse nanocrystals. Nano Lett 2007, 7:847-852.
104. 3:Yb,Tm nanocrystals with multicolor upconversion fluorescence. J Mater Chem 2005, 15:4460-4464.
105. Silver J, Martinez-Rubio MI, Ireland TG, Fern GR, Withnall R. The effect of particle morphology and crystallite size on the upconversion luminescence properties of erbium and ytterbium co-doped yttrium oxide phosphors. J Phys Chem B 2001, 105:948-953.
106. Wang M, Li F, Xu SK. Synthesis of ytterbium and erbium co-doped sodium yttrium fluoride upconversion fluorescence materials. Luminescence 2008, 23:100.
107. Wei Y, Lu FQ, Zhang XY, Chen DP. Synthesis and characterization of efficient near-infrared upconversion Yb and Tmcodoped NaYF4 nanocrystal reporter. J Alloys Compd 2007, 427:333-340.
108. 3+ nanocrystals for bioapplications. Nanotechnology 2006, 17:1527-1532.
109. Wang LY, Yan RX, Hao ZY, Wang L, Zeng JH, et al. Fluorescence resonant energy transfer biosensor based on upconversion-luminescent nanoparticles. Angew Chem Int Ed 2005, 44:6054-6057.
110. 6 single-crystal nanorods as multicolor luminescent materials. Nano Lett 2006, 6:1645-1649.
111. 4 (Ln = Y, Dy-Yb). Inorg Chem 2007, 46:5404-5410.
112. 3+ (Ln = Eu, Tb, Yb/Er, and Yb/Tm) hexagonal microprism crystals: hydrothermal synthesis and luminescent properties. Inorg Chem 2007, 46:6329-6337.
113. 3+ phosphors of controlled size and morphology. Adv Mater 2005, 17:2119-2123.
114. Wang M, Liu JL, Zhang YX, Hou W, Wu XL, et al. Two-phase solvothermal synthesis of rare-earth doped NaYF4 upconversion fluorescent nanocrystals. Mater Lett 2009, 63:325-327.
115. Rillings KW, Roberts JE. Thermal study of the trifluoroacetates and pentafluoropropionates of praseodymium, samarium, and erbium. Thermochim Acta 1974, 10:285-298.
116. 4 core - shell nanocystals. Chem Mater 2007, 19:3358-3360.
117. 4:Yb, Er core and core/shell-structured nanocrystals. J Phys Chem C 2007, 111:13721-13729.
118. 4 core/shell nanoparticles: excitation power density and surface dependence. J Phys Chem C 2009, 113:7164-7169.
119. 4/Polymer core/shell/shell nanoparticles with significant enhancement of upconversion fluorescence. Chem Mater 2007, 19:341-343.
120. 4 nanocrystals in aqueous solution displaying strong up-conversion emission. Chem Mater 2007, 19:1396-1400.
121. Li ZQ, Zhang Y, Jiang S. Multicolor core/shell-structured upconversion fluorescent nanoparticles. Adv Mater 2008, 20:4765-4769.
122. 3+ nanoparticles with improvement in upconversion luminescence induced by different thickness shells. J Appl Phys 2008, 103:123533.
123. 4 upconversion nanophosphors. J Appl Phys 2008, 104:094308.
124. 4 nanoparticles with upconversion fluorescence. Nanotechnology 2006, 17:5786-5791.
125. Chen ZG, Chen HL, Hu H, Yu MX, Li FY, et al. Versatile synthesis strategy for carboxylic acid-functionalized upconverting nanophosphors as biological labels. J Am Chem Soc 2008, 130:3023-3029.
126. Chatterjee DK, Rufaihah AJ, Zhang Y. Upconversion fluorescence imaging of cells and small animals using lanthanide doped nanocrystals. Biomaterials 2008, 29:937-943.
127. Kunishi T, Yamada M, Soga K, Matsuura D, Nagasaki Y. PEG-based surface modification on upconversion nanophosphors for bio-imaging under IR excitation. J Photopolym Sci Technol 2006, 19:145-149.
128. Zako T, Nagata H, Terada N, Utsumi A, Sakono M, et al. Cyclic RGD peptide-labeled upconversion nanophosphors for tumor cell-targeted imaging. Biochem Biophys Res Commun 2009, 381:54-58.
129. Kumar R, Nyk M, Ohulchanskyy TY, Flask CA, Prasad PN. Combined optical and MR bioimaging using rare earth ion doped NaYF4 nanocrystals. Adv Funct Mater 2009, 19:853-859.
130. Lim SF, Riehn R, Ryu WS, Khanarian N, Tung CK, et al. In vivo and scanning electron microscopy imaging of upconverting nanophosphors in Caenorhabditis elegans. Nano Lett 2006, 6:169-174.
131. Hilderbrand SA, Shao FW, Salthouse C, Mahmood U, Weissleder R. Upconverting luminescent nanomaterials: application to in vivo bioimaging. Chem Commun 2009, 28:4188-4190.
132. Koole R, Mulder WJM, van Schooneveld MM, Strijkers GJ, Meijerink A, et al. Magnetic Quantum Dots for Multimodal Imaging. WIREs Nanomed Nanobiotechnol 2009, 475-491.
133. Cormode DP, Skajaa T, van Schooneveld MM, Koole R, Jarzyna P, et al. Nanocrystal core high-density lipoproteins: a multimodality contrast agent platform. Nano Lett 2008, 8:3715-3723.
134. Cai WB, Chen K, Li ZB, Gambhir SS, Chen XY. Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature. J Nucl Med 2007, 48:1862-1870.